Multicenter phase II trial of S-1 in patients with cytokine-refractory ... - UroToday PDF Print
UroToday
This phase II multicenter trial was conducted to evaluate the activity and safety of S-1 in Japanese patients with metastatic renal cell carcinoma (mRCC).

...

 
Share |
Copyright © 2026 Global Dialysis. All Rights Reserved.